Jerry R. Paugh

Dr. Jerry R. Paugh


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2019 in Cornea
Verified
Journal Article
Closed access
JPJerry R. Paugh
Jerry R. Paugh
JTJune Od Tse
June Od Tse
TNTiffany Od Nguyen
Tiffany Od Nguyen
ASAlan Od Sasai
Alan Od Sasai
ECElaine Od Chen
Elaine Od Chen
JJJames V. Jester
James V. Jester
Purpose: To examine the effects of volume and method on fluorescein tear breakup time (TBUT) values and to evaluate test efficacy in an independent sample free of selection bias. Methods: Subjects were assessed using a battery of dry eye tests (DETs). Efficacy study: Subjects were randomized to the DET, standard strip, and liquid NaFl on separate days. A masked examiner measured TBUTs from video recordings. Verification study: Subjects were investigated for efficacy using volumes of 5.0 and 2.0 μL mL of NaFl for TBUT. Results: Efficacy study: 46 subjects completed the study. Log-transformed TBUTs were significantly different, normal subjects versus dry subjects, for all 3 methods (all P values < 0.001). Area under the curves (AUCs), cut-points, sensitivity, and specificity were 1) DET: 0.873, 4.4 seconds, 0.97, and 0.67, respectively; 2) 2.0 mL: 0.901, 3.22 seconds, 0.90, and 0.87, respectively; and 3) standard strip: 0.912, 3.42 seconds, 0.97, and 0.80, respectively. Verification study: Data splitting analysis for the 2.0 μL data (n = 174 dry subjects and 97 normal subjects) generated an AUC of 0.917 and a cut-point of 6.05 seconds for a sensitivity of 0.87 and a specificity of 0.81. The 5.0 μL sample yielded an AUC of 0.940, with a sensitivity and specificity of 0.92 and 0.83, respectively, at a cut-point of 5.5 seconds. Conclusions: Little difference in TBUT was found using the 3 clinical methods with video recordings. Analysis using liquid NaFl suggests that the TBUT test has excellent diagnostic accuracy and that a cut-point of 5.3 to 6.0 seconds is the optimum to differentiate normals from persons with dry eye.

1 March 2018 in Eye & Contact Lens: Science & Clinical Practice
Verified
Journal Article
Closed access
JPJerry R. Paugh
Jerry R. Paugh
ECElaine O.D. Chen
Elaine O.D. Chen
CHColton O.D. Heinrich
Colton O.D. Heinrich
HMHeidi O.D. Miller
Heidi O.D. Miller
TGTiffany O.D. Gates
Tiffany O.D. Gates
BWBarry A. O.D. Weissman
Barry A. O.D. Weissman
Objectives: To quantify tear elimination rate (ER) underneath silicone hydrogel (Si-Hy) and scleral gas permeable (GP) contact lenses (CLs). Methods: Subjects successfully using either well-fitting soft Si-Hy CLs or scleral GP CLs were recruited. Most scleral GP CL wearers had irregular corneas (e.g., keratoconus). An objective fluorometer measured decay of fluorescein isothiocyanate dextran dye signal (70 kD MW) from which the tear ER in %/min was calculated. For GP scleral lenses, the ER was determined for both the initial settling period and the 30- to 60-min period, and without lenses. All ERs were calculated from 5 to 30 min to avoid reflex tearing effects. Results: Fourteen soft Si-Hy CL and 12 scleral GP CL wearers completed the study. The ER for the scleral GP CL wearers averaged 0.57 (±0.6) %/min for the 0- to 30-min and 0.42 (±0.5) %/min for the 30- to 60-min period (P=0.515). Non-CL wear tear ER in these same subjects averaged 34.17 (±15.9) %/min and was significantly different versus both scleral GP wear periods (both P values <0.001). The ER for the soft Si-Hy CL wearers, 5 to 30 min, averaged 6.09 (±2.8) %/min. Conclusions: Our data demonstrate significantly less ER in well-fit scleral GP CL wearers compared with soft Si-Hy CL wearers for both the settling and longer wear periods (both P values <0.001). Moreover, slightly greater tear exchange was observed during the scleral GP CL settling period than later, which may reflect a change over time in tear vault thickness.

1 January 2019 in The Ocular Surface
Verified
Journal Article
Closed access
JPJerry R. Paugh
Jerry R. Paugh
AAAlba Alfonso-Garcia
Alba Alfonso-Garcia
ANAndrew Loc Nguyen
Andrew Loc Nguyen
JSJeffrey L. Suhalim
Jeffrey L. Suhalim
MFMarjan Farid
Marjan Farid
JJJames Jester
James Jester

1 January 2018 in Eye & Contact Lens: Science & Clinical Practice
Verified
Journal Article
Closed access
PDF file
JPJerry R. Paugh
Jerry R. Paugh
JKJustin Kwan
Justin Kwan
MCMichael Christensen
Michael Christensen
ANAndrew Loc Nguyen
Andrew Loc Nguyen
MSMichelle Senchyna
Michelle Senchyna
DMDavid Meadows
David Meadows
Objectives: The aim of this study was to develop and evaluate, using psychometric approaches, a meibomian gland dysfunction (MGD)-specific questionnaire in noncontact lens wearers. Methods: The MGD subjects were recruited and classified as the MGD dry eye subtype based on accepted tests (e.g., Schein symptom survey, tear breakup time, corneal and conjunctival staining, abnormal meibum or meibomian gland atrophy, and a normal Schirmer test). The MGD questionnaire items were drawn from published and anecdotal sources. The preliminary instrument contained 24 items targeting the frequency and intensity of 12 symptoms. Rasch analysis was used for psychometric evaluation of the survey items. Results: Sixty nine MGD subjects completed the survey and clinical testing. Sample severity levels were as follows: none subclinical, 10 minimal, 43 mild, 16 moderate, and none severe. Three iterations of analysis, eliminating INFIT and OUTFIT scores <, and >3.0, and using subject responses reduced the final questionnaire to seven question pairs. Final analysis for the remaining 14 items demonstrated an excellent fit to the Rasch model (e.g., for persons, INFIT MNSQ=0.97; ZSTD=−0.2; OUTFIT MNSQ=0.96; ZSTD=−0.2; item fit statistics were similar). Construct validity also seems good (e.g., correlation to Schein and change with treatment). Conclusions: The MGD-specific instrument is a valid quantitative measure of the symptoms stemming from MGD sufferers. Further research is necessary to determine whether diagnostic efficacy is sufficient to differentiate the MGD dry eye subtype in an independent sample of normals and both major dry eye subtypes exhibiting a broad severity range.

14 June 2025 in The Ocular Surface
Verified
Journal Article
Closed access
JJJay Ruzhang Jiang
Jay Ruzhang Jiang
RKRima Khankan
Rima Khankan
WRWilliam H. Ridder
William H. Ridder
NLNguyen Andrew Loc
Nguyen Andrew Loc
JPJerry R. Paugh
Jerry R. Paugh

10 February 2022 in Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
JPJerry R. Paugh
Jerry R. Paugh
TNTiffany Nguyen
Tiffany Nguyen
ASAlan Sasai
Alan Sasai
ECElaine Y Chen
Elaine Y Chen
MJMelinda Thomas De Jesus
Melinda Thomas De Jesus
JJJames V. Jester
James V. Jester
Objectives. To determine the efficacy of widely available subtype clinical tests to characterize evaporative dry eye disease (EDED) related to meibomian gland dysfunction (MGD) compared to normal and to validate those clinical cut points in an independent sample. Methods. A diagnostic accuracy study (52 subjects), an investigator-masked study, was followed by a larger independent sample (364 subjects) analysis to confirm efficacy in normal and EDED subjects. All subjects were 18 years of age and older and were classified using a battery of clinical tests for dry eye that included symptoms, tear meniscus height, tear stability, ocular staining, evaporative-specific tests, and the Schirmer I test. Results. Normal (nondry eye; n=26) and EDED (n=26) subjects completed the efficacy study. The global tests of tear breakup time, staining, and symptoms all produced AUCs 0.70, representing acceptable discrimination. EDED-specific tests of eyelid marginal signs, gland secretion quality, and gland loss did not demonstrate acceptable test efficacy or differences between normal and EDED subjects. In a larger, independent sample of normal and EDED subjects, gland secretion quality and eyelid marginal score achieved acceptable diagnostic levels: AUCs of 0.789 (CI: 0.7340.844) and 0.729 (CI: 0.6480.810), respectively, but not lipid interferometry grade or lower eyelid gland dropout estimated using meiboscopy. Conclusions. Meibomian gland secretion quality is an efficient and useful functional indicator in EDED and should be incorporated into core outcome sets for this dry eye subtype.